Vaniprevir is a direct-acting antiviral small molecule that competitively inhibits the hepatitis C virus NS3/4A protease, thereby blocking viral replication. It has been utilized in both in vitro enzymatic assays and in vivo animal studies to investigate HCV protease function and antiviral therapy.
Molecular Weight:
757.94
Purity:
97.41% (May vary between batches)
CAS Number:
[923590-37-8]
Formula:
C38H55N5O9S
Target:
HCV Protease
Application Notes:
Solubility: DMSO:8 mg/mL (10.55 mM)
* VAT and and shipping costs not included. Errors and price changes excepted
